Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

W. I. McDonald(Royal College of Physicians), Alistair Compston(University of Cambridge), Gilles Edan(Centre Hospitalier Universitaire de Rennes), Donald E. Goodkin(University of California, San Francisco), Hans‐Peter Hartung(University of Graz), Fred Lublin(Icahn School of Medicine at Mount Sinai), Henry F. McFarland(National Institutes of Health), Donald W. Paty(University of British Columbia), Chris H. Polman(Vrije Universiteit Amsterdam), Stephen C. Reingold(National Multiple Sclerosis Society), Magnhild Sandberg‐Wollheim(Lund University), W. A. Sibley(University of Arizona), Alan J. Thompson(UCL Australia), Stanley van den Noort(University of California, Irvine), Brian Weinshenker(Mayo Clinic), Jerry S. Wolinsky(The University of Texas Health Science Center at Houston)
Annals of Neurology
June 26, 2001
Cited by 6,949

Abstract

The International Panel on MS Diagnosis presents revised diagnostic criteria for multiple sclerosis (MS). The focus remains on the objective demonstration of dissemination of lesions in both time and space. Magnetic resonance imaging is integrated with dinical and other paraclinical diagnostic methods. The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including "monosymptomatic" disease suggestive of MS, disease with a typical relapsing-remitting course, and disease with insidious progression, without clear attacks and remissions. Previously used terms such as "clinically definite" and "probable MS" are no longer recommended. The outcome of a diagnostic evaluation is either MS, "possible MS" (for those at risk for MS, but for whom diagnostic evaluation is equivocal), or "not MS."


Related Papers

No related papers found

Powered by citation graph analysis